MedTrace Logo

Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine

NCT01179412 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2010-08-11

No results posted yet for this study

Summary

The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.

Conditions

  • Viral Conjunctivitis

Interventions

DRUG

2% povidone-iodine

apply 4 times a day for one week

DRUG

2% povidone-iodine

apply 2% povidone-iodine 4 times per day for one week

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Adisak Trinavarat, MD · Siriraj Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01179412 on ClinicalTrials.gov